Biogen reported $10.9B in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Bayer BAYN:GR € 33020M 1917M
Bluebird Bio BLUE:US $ 374.28M 496.25M
Novartis NOVN:VX SF 67655M 10884M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Teva Pharmaceutical TEVA:IT 10.28B 189M